LGC Capital Initiated as a BUY: Ubika Alpha

Equity Research Healthcare – Cannabis | March 12, 2019
Patrick Smith | Analyst | Ubika Research Patrick@UbikaResearch.com | (647) 444-5506
Christopher, Bednarz MBA | Associate | Chris.B@UbikaResearch.com | (416) 558-5548

Ubika Alpha has initiated coverage of LGC Capital Ltd. (TSXV:LG) shares with a BUY rating and a 12-month target of $0.20/share, implying a rate of return of 111%

Company Description: LGC Capital Ltd. is a Canada-based investment holdings company focused on acquiring production, brands, and distribution in mature and emerging cannabis markets. Through its portfolio of companies, LGC Capital has a unique focus on international markets. As international markets continue to expand, the Canadian and U.S. markets should take notice, and international cannabis plays that invested in the early stages should have premium positions in the market. The Company mainly directs its investments to companies with high-margin product offerings, which include edibles, concentrates, oils, vapes, and CBD-based products.


(Currency is CAD$ & estimates are attributable, unless noted otherwise)

Last Price $0.095

Target Price$0.20

Potential Return111%

Net Asset Value Per Share $0.21

52 Week Low / High$0.08 / $0.25

Average Daily Volume (30-Day)806K

Shares Outstanding (M) 495.0 600.9
Market Capitalization ($M) $47.0
Enterprise Value ($M) $33.8
Cash Balance ($M) $15.5
Total Debt ($M) $2.3
Flower Produced (kg) - 100% 10,700 30,800 51,800
Revenue ($M) $15.6 $37.8 $65.8
Cash Costs ($ per gram) $0.96 $1.00 $0.96
AICC ($ per gram) $2.31 $2.10 $1.66
EBITDA ($M) -$0.7 $7.3 $23.6
FCF ($M) -$14.1 -$15.1 $0.1
Total CAPEX ($M) $12.7 $19.0 $14.6
CFPS $0.00 $0.01 $0.03
Cash At Year End ($M) $6.1 $3.0 $2.6
Debt At Year End ($M) $2.5 $6.0 $6.0
Relative Valuation P/NAV EV/EBITDA
2019E 2020E
LGC Capital Ltd 0.5x nm 4.6x
Cannabis Holdings Companies n/a 5.4x 6.4x
Gold and Oil Royalty Companies 1.4x 8.5x 8.0x
Management & Insiders (21.3%)
Disclosure: None (See back page for further details)



  • A compelling international portfolio of assets with brands and distribution across four continents. LGC Capital is focused on identifying and developing successful consumer brands. In terms of a cultivation footprint, LGC has access to more than 450,000 sq. ft. with plans to increase this to 2.1M sq. ft. on a fully consolidated basis by 2020E. For reference, Canopy Growth Corp. (TSX:WEED, $60.81 | N/R), the largest cannabis company by market cap at $21B, has ~1.3M sq. ft. under construction.
  • LGC has invested $29M to date. These investments range from modest ownership of vertically-integrated operators in mature medical markets to cultivation/sales licenses in geographies ripe with potential for significant recreational upside. To date, the Company has made investments across five countries.


  • We are initiating coverage of LGC Capital with a BUY rating and a target price of $0.20/share. We utilize a 50/50 blended net asset value (NAV) and EV/EBITDA methodology for our valuation. For NAV, we use a 10-year DCF, discounted one-year out for $0.21/share. For EV/EBITDA, we utilized a conservative 4.0x multiple, consistent with cannabis holdings companies and intermediate cannabis producers, applied to our 2021E EBITDA estimate, equating to $0.18/share. We utilize a fully-financed share count, which presumes an $8.0M raise at $0.10 and $6.0M in debt at a 10% interest rate.
  • Trades at a discount to peers. LGC currently trades at 4.6x our 2020E EBITDA estimates of $23.6M, a discount to cannabis holdings companies and gold and oil royalty companies, which trade at an average of 6.4x and 8.0x, respectively. We believe this gap should close as LGC begins to make material cash flow.

To read our full disclosure, please click on the button below: